Bio-Rad Laboratories, Inc. Class A Common Stock vs Brookfield Infrastructure Partners LP — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $298.3 (market cap $8.02B), while Brookfield Infrastructure Partners LP trades at $38.19 (market cap $17.25B). The key difference: Brookfield Infrastructure Partners LP is far larger — about 2.2× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and Brookfield Infrastructure Partners LP pays a 4.84% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | BIP | |
|---|---|---|
Market Cap | $8.02B | $17.25B |
Sector | Health | Industrials |
52-Week High | $339.75 | $40.08 |
52-Week Low | $241.71 | $29.81 |
Enterprise Value | $7.84B | $78.92B |
Dividend Yield | — | 4.84% |
Trailing returns across standard periods
Latest headlines on both assets
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Brookfield Infrastructure owns and operates high-quality global assets across utilities, transport, midstream, and data sectors. It focuses on generating stable, long-term cash flows from essential infrastructure.
Read more on BIP →